Treatment

Neulasta 6 mg solution for injection clinical trials

2 indexed studies · 0 currently recruiting

Ongoing, recruitingTherapeutic exploratory (Phase II)
REFRaME-O1: A Phase 2/3 Open-label Study Evaluating the Efficacy and Safety of Luveltamab Tazevibulin (STRO-002) versus Investigator’s Choice (IC) Chemotherapy in Women with Relapsed Platinum-resistant Epithelial Ovarian Cancer (Including Fallopian Tube or Primary Peritoneal Cancers) Expressing Folate Receptor Alpha (FOLR1)
This study is for women with advanced ovarian (or related) cancer that has come back and isn't responding to platinum-based chemotherapy. Researchers are comparing a new treatment called Luveltamab Tazevibulin with standard chemotherapy to see if it works better and is safe.
For: Advanced Epithelial Ovarian Cancer (including Fallopian Tube or Primary Peritoneal cancers)
Austria · Finland · Czechia
AuthorisedTherapeutic exploratory (Phase II)
Use of pegfilgrastim in severe chronic neutropenia
This study is looking at a medicine called Neulasta for people with a rare blood condition called severe chronic neutropenia. It aims to see if Neulasta can help increase a type of white blood cell, which is important for fighting infections, over several months.
For: Severe chronic neutropenia (SCN)
Italy